AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
LABELING OF RECOMBINANT HIRUDIN BY FITC AND ANALYSIS ON HUMAN BLOOD-CELLS
Authors: MALSCH R WANG LC HUHLE G TIMMERMANN A
Citation: R. Malsch et al., LABELING OF RECOMBINANT HIRUDIN BY FITC AND ANALYSIS ON HUMAN BLOOD-CELLS, Thrombosis and haemostasis, 1997, pp. 363-363
LASER-INDUCED DETECTION OF FLUORESCENT-LABELED HIRUDIN USING CAPILLARY ELECTROPHORESIS METHODS
Authors: TIMMERMANN A MALSCH R HUHLE G HARENBERG J
Citation: A. Timmermann et al., LASER-INDUCED DETECTION OF FLUORESCENT-LABELED HIRUDIN USING CAPILLARY ELECTROPHORESIS METHODS, Thrombosis and haemostasis, 1997, pp. 369-369
COMPARISON OF THE BIOLOGICAL-ACTIVITIES OF DERMATAN SULFATE, LMW-DERMATAN-SULFATE AND LMW-DERMATAN-SULFATE-TYRAMIN AFTER IV APPLICATION
Authors: PIAZOLO L DANNEIL C MALSCH R HUTTNER FG HARENBERG J HEENE DL
Citation: L. Piazolo et al., COMPARISON OF THE BIOLOGICAL-ACTIVITIES OF DERMATAN SULFATE, LMW-DERMATAN-SULFATE AND LMW-DERMATAN-SULFATE-TYRAMIN AFTER IV APPLICATION, Thrombosis and haemostasis, 1997, pp. 386-386
MONITORING OF THE ANTICOAGULANT EFFECTS OF COMBINED (OVERLAPPING) TREATMENT OF PEG-HIRUDIN AND HEPARIN USING THE ECARIN CLOTTING TIME
Authors: ESSLINGER HU HUHLE G KESSLER M DUBBERS K MALSCH R PIAZOLO L HARENBERG J
Citation: Hu. Esslinger et al., MONITORING OF THE ANTICOAGULANT EFFECTS OF COMBINED (OVERLAPPING) TREATMENT OF PEG-HIRUDIN AND HEPARIN USING THE ECARIN CLOTTING TIME, Thrombosis and haemostasis, 1997, pp. 1138-1138
INFLUENCE OF THE COMBINATION OF PEG-HIRUDIN AND HEPARIN ON BLOOD-COAGULATION
Authors: GIESE C HARENBERG J MALSCH R HUHLE G PIAZOLO L ESSLINGER HU
Citation: C. Giese et al., INFLUENCE OF THE COMBINATION OF PEG-HIRUDIN AND HEPARIN ON BLOOD-COAGULATION, Thrombosis and haemostasis, 1997, pp. 1146-1146
INTRAVENOUS AND SUBCUTANEOUS PHARMACODYNAMICS AND PHARMACOKINETICS OFLMW-HEPARIN AND LMW-HEPARIN-TYRAMIN-FITC
Authors: PIAZOLO L HUTTNER FG MALSCH R HARENBERG J HEENE DL
Citation: L. Piazolo et al., INTRAVENOUS AND SUBCUTANEOUS PHARMACODYNAMICS AND PHARMACOKINETICS OFLMW-HEPARIN AND LMW-HEPARIN-TYRAMIN-FITC, Thrombosis and haemostasis, 1997, pp. 1210-1210
DISTRIBUTION OF L-INDURONIC-ACID AND GLUCURONIC-ACID IN GLYCOSAMINOGLYCANS BY THE MONOCLONAL-ANTIBODY H1.18
Authors: HUHLE G MALSCH R HARENBERG J HEENE DL
Citation: G. Huhle et al., DISTRIBUTION OF L-INDURONIC-ACID AND GLUCURONIC-ACID IN GLYCOSAMINOGLYCANS BY THE MONOCLONAL-ANTIBODY H1.18, Thrombosis and haemostasis, 1997, pp. 1216-1216
ANALYSIS OF DIFFERENT GLYCOSAMINOGLYCANS USING AGAROSE-GEL ELECTROPHORESIS AND AZURE A-SILVER STRAINING
Authors: WANG LC MALSCH R
Citation: Lc. Wang et R. Malsch, ANALYSIS OF DIFFERENT GLYCOSAMINOGLYCANS USING AGAROSE-GEL ELECTROPHORESIS AND AZURE A-SILVER STRAINING, Thrombosis and haemostasis, 1997, pp. 1220-1220
COMPETITIVE FLUORESCENT LINKED HEPARIN-BINDING ASSAY USING PROTAMINE COATED DYNABEADS
Authors: MALSCH R MELUI D PIAZOLO L HARENBERG J HEENE DL
Citation: R. Malsch et al., COMPETITIVE FLUORESCENT LINKED HEPARIN-BINDING ASSAY USING PROTAMINE COATED DYNABEADS, Thrombosis and haemostasis, 1997, pp. 1221-1221
INTERACTIONS OF COMBINED (OVERLAPPING) TREATMENT WITH PEG-HIRUDIN ANDHEPARIN IN HEALTHY-VOLUNTEERS
Authors: HARENBERG J HUHLE G KESSLER M MALSCH R PIAZOLO L DUBBERS K ESSLINGER HU
Citation: J. Harenberg et al., INTERACTIONS OF COMBINED (OVERLAPPING) TREATMENT WITH PEG-HIRUDIN ANDHEPARIN IN HEALTHY-VOLUNTEERS, Thrombosis and haemostasis, 1997, pp. 2008-2008
DETECTION OF HIRUDIN ANTIBODIES USING A FLUOR-IMAGING METHOD
Authors: WANG LC MALSCH R HUHLE G HARENBERG J
Citation: Lc. Wang et al., DETECTION OF HIRUDIN ANTIBODIES USING A FLUOR-IMAGING METHOD, Thrombosis and haemostasis, 1997, pp. 2015-2015
LOW-MOLECULAR-WEIGHT HEPARINS IN THE PROP HYLAXIS AND TREATMENT OF THROMBOEMBOLIC DISEASES
Authors: HARENBERG J HUHLE G PIAZOLO L MALSCH R
Citation: J. Harenberg et al., LOW-MOLECULAR-WEIGHT HEPARINS IN THE PROP HYLAXIS AND TREATMENT OF THROMBOEMBOLIC DISEASES, Hautarzt, 48(11), 1997, pp. 852-864
PURIFICATION OF THE MONOCLONAL HEPARIN ANTIBODY H-1.18
Authors: MALSCH R MROTZEK T HUHLE G HARENBERG J
Citation: R. Malsch et al., PURIFICATION OF THE MONOCLONAL HEPARIN ANTIBODY H-1.18, Journal of chromatography, 744(1-2), 1996, pp. 215-221
CHROMATOGRAPHIC AND ELECTROPHORETIC APPLICATIONS FOR THE ANALYSIS OF HEPARIN AND DERMATAN SULFATE
Authors: MALSCH R HARENBERG J PIAZOLO L HUHLE G HEENE DL
Citation: R. Malsch et al., CHROMATOGRAPHIC AND ELECTROPHORETIC APPLICATIONS FOR THE ANALYSIS OF HEPARIN AND DERMATAN SULFATE, Journal of chromatography B. Biomedical applications, 685(2), 1996, pp. 223-231
MULTICENTRIC EVALUATION OF HEPARINASE ON APTT, THROMBIN CLOTTING TIMEAND A NEW PT REAGENT BASED ON RECOMBINANT HUMAN TISSUE FACTOR
Authors: HARENBERG J REICHEL T MALSCH R HIRSH J RUSTAGI P
Citation: J. Harenberg et al., MULTICENTRIC EVALUATION OF HEPARINASE ON APTT, THROMBIN CLOTTING TIMEAND A NEW PT REAGENT BASED ON RECOMBINANT HUMAN TISSUE FACTOR, Blood coagulation & fibrinolysis, 7(4), 1996, pp. 453-458
ANTICOAGULANT EFFECTS AND TISSUE FACTOR PATHWAY INHIBITOR AFTER INTRAPULMONARY LOW-MOLECULAR-WEIGHT HEPARIN
Authors: HARENBERG J MALSCH R ANGELESCU M LANGE C MICHAELIS HC WOLF H HEENE DL
Citation: J. Harenberg et al., ANTICOAGULANT EFFECTS AND TISSUE FACTOR PATHWAY INHIBITOR AFTER INTRAPULMONARY LOW-MOLECULAR-WEIGHT HEPARIN, Blood coagulation & fibrinolysis, 7(4), 1996, pp. 477-483
EFFECTS OF LOW-MOLECULAR-WEIGHT DERMATAN SULFATE ON COAGULATION, FIBRINOLYSIS AND TISSUE FACTOR PATHWAY INHIBITOR IN HEALTHY-VOLUNTEERS
Authors: HARENBERG J JESCHEK M ACKER M MALSCH R HUHLE G HEENE DL
Citation: J. Harenberg et al., EFFECTS OF LOW-MOLECULAR-WEIGHT DERMATAN SULFATE ON COAGULATION, FIBRINOLYSIS AND TISSUE FACTOR PATHWAY INHIBITOR IN HEALTHY-VOLUNTEERS, Blood coagulation & fibrinolysis, 7(1), 1996, pp. 49-56
ANALYSIS OF HEPARIN-BINDING TO HUMAN-LEUKOCYTES USING A FLUORESCEIN-5-ISOTHIOCYANATE LABELED HEPARIN FRAGMENT
Authors: HARENBERG J MALSCH R PIAZOLO L HUHLE G HEENE DL
Citation: J. Harenberg et al., ANALYSIS OF HEPARIN-BINDING TO HUMAN-LEUKOCYTES USING A FLUORESCEIN-5-ISOTHIOCYANATE LABELED HEPARIN FRAGMENT, Cytometry, 23(1), 1996, pp. 59-66
PURITY OF GLYCOSAMINOGLYCAN-RELATED COMPOUNDS USING CAPILLARY ELECTROPHORESIS
Authors: MALSCH R HARENBERG J
Citation: R. Malsch et J. Harenberg, PURITY OF GLYCOSAMINOGLYCAN-RELATED COMPOUNDS USING CAPILLARY ELECTROPHORESIS, Electrophoresis, 17(2), 1996, pp. 401-405
THERAPY OF THROMBOSIS - NEW DEVELOPMENTS
Authors: HARENBERG J HUHLE G PIAZOLO L MALSCH R
Citation: J. Harenberg et al., THERAPY OF THROMBOSIS - NEW DEVELOPMENTS, Die medizinische Welt, 47(3), 1996, pp. 103-107
PREFERENTIAL BINDING OF HEPARIN TO GRANULOCYTES OF VARIOUS SPECIES
Authors: HARENBERG J MALSCH R PIAZOLO L HUHLE G HEENE DL
Citation: J. Harenberg et al., PREFERENTIAL BINDING OF HEPARIN TO GRANULOCYTES OF VARIOUS SPECIES, American journal of veterinary research, 57(7), 1996, pp. 1016-1020
HIGH-RESOLUTION CAPILLARY ELECTROPHORESIS AND POLYACRYLAMIDE-GEL ELECTROPHORESIS OF HEPARINS
Authors: MALSCH R HARENBERG J HEENE DL
Citation: R. Malsch et al., HIGH-RESOLUTION CAPILLARY ELECTROPHORESIS AND POLYACRYLAMIDE-GEL ELECTROPHORESIS OF HEPARINS, Journal of chromatography, 716(1-2), 1995, pp. 259-268
TISSUE FACTOR PATHWAY INHIBITOR - PROPOSED HEPARIN RECOGNITION REGION
Authors: HARENBERG J MALSCH R HEENE DL
Citation: J. Harenberg et al., TISSUE FACTOR PATHWAY INHIBITOR - PROPOSED HEPARIN RECOGNITION REGION, Blood coagulation & fibrinolysis, 6, 1995, pp. 50-56
TISSUE FACTOR PATHWAY INHIBITOR - A PROPOSED HEPARIN RECOGNITION REGION
Authors: HARENBERG J MALSCH R HEENE DL
Citation: J. Harenberg et al., TISSUE FACTOR PATHWAY INHIBITOR - A PROPOSED HEPARIN RECOGNITION REGION, Thrombosis and haemostasis, 73(6), 1995, pp. 943-943
HEPARIN-ANTIBODIES THEIR PREPARATION, DISCUSSION AND ACTIVITY IN BIOLOGICAL TEST SYSTEMS
Authors: HUHLE G MALSCH R HARENBERG J HEENE DL
Citation: G. Huhle et al., HEPARIN-ANTIBODIES THEIR PREPARATION, DISCUSSION AND ACTIVITY IN BIOLOGICAL TEST SYSTEMS, Thrombosis and haemostasis, 73(6), 1995, pp. 965-965
Risultati: 1-25 | 26-50 | 51-54